ST. LOUIS, May 1 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS), announced today that Bevil J. Hogg, Chief Executive Officer, and James M. Stolze, Chief Financial Officer, will present at the Deutsche Bank 33rd Annual Health Care Conference in Boston on Wednesday, May 7, 2008 at 8:50 a.m. Eastern Time.

Attendance at the conference is by invitation only. The audio presentation will be webcast live and remain available for 90 days at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=STXS&item_id=1827565.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.

SOURCE  Stereotaxis, Inc.
    -0-                             05/01/2008
    /CONTACT:  Jim Stolze, Chief Financial Officer of Stereotaxis, Inc.,
+1-314-678-6105; or Investors, Doug Sherk, or Jenifer Kirtland, both of EVC
Group, Inc., +1-415-896-6820, for Stereotaxis, Inc., or Media, Steve DiMattia
of EVC Group, Inc., +1-646-201-5445, for Stereotaxis, Inc./
    /Web site:  http://www.stereotaxis.com /
    (STXS)

CO:  Stereotaxis, Inc.; Deutsche Bank 33rd Annual Health Care Conference
ST:  Missouri, Massachusetts
IN:  HEA BIO MTC SPM
SU:  TDS CCA

SA-DW
-- AQTH134 --
6000 05/01/2008 16:05 EDT http://www.prnewswire.com